Total Payments
$6,713
2024 Payments
$903.07
Companies
33
Transactions
240
Medicare Patients
5,245
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$4,731 (70.5%)
Travel$1,331 (19.8%)
Education$651.13 (9.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,731 | 221 | 70.5% |
| Travel and Lodging | $1,331 | 9 | 19.8% |
| Education | $651.13 | 10 | 9.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,761 | 26 | $0 (2024) |
| Astellas Pharma US Inc | $1,641 | 82 | $0 (2024) |
| Coloplast Corp | $782.38 | 9 | $0 (2020) |
| PFIZER INC. | $477.85 | 33 | $0 (2024) |
| 180 Medical, Inc. | $292.07 | 12 | $0 (2024) |
| Laborie Medical Technologies Corp. | $257.20 | 2 | $0 (2023) |
| Endo Pharmaceuticals Inc. | $244.02 | 8 | $0 (2021) |
| Janssen Biotech, Inc. | $236.32 | 29 | $0 (2024) |
| Neomend, Inc. | $122.71 | 1 | $0 (2017) |
| NeoTract Inc. | $119.62 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $903.07 | 31 | Astellas Pharma US Inc ($332.77) |
| 2023 | $692.55 | 29 | Astellas Pharma US Inc ($240.64) |
| 2022 | $884.77 | 31 | Astellas Pharma US Inc ($322.33) |
| 2021 | $384.58 | 20 | Astellas Pharma US Inc ($258.29) |
| 2020 | $242.99 | 15 | Astellas Pharma US Inc ($57.35) |
| 2019 | $676.46 | 60 | Astellas Pharma US Inc ($168.53) |
| 2018 | $443.14 | 18 | BOSTON SCIENTIFIC CORPORATION ($175.12) |
| 2017 | $2,486 | 36 | BOSTON SCIENTIFIC CORPORATION ($1,315) |
All Payment Transactions
240 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $102.36 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Sagent Pharmaceuticals | Glydo (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Topical local anesthetic | ||||||
| 11/08/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $25.86 | General |
| 10/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: Oncology | ||||||
| 10/21/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $24.08 | General |
| 10/21/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Urology | ||||||
| 10/16/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: Immunotherapy | ||||||
| 10/15/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: rezum_URO | ||||||
| 10/09/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $34.07 | General |
| Category: Oncology | ||||||
| 08/22/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $8.87 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $4.77 | General |
| Category: ONCOLOGY | ||||||
| 08/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: UROLOGY | ||||||
| 08/15/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $25.11 | General |
| 07/18/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/26/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 06/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $8.43 | General |
| Category: Biological | ||||||
| 06/18/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/31/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $7.72 | General |
| Category: ONCOLOGY | ||||||
| 05/30/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: ONCOLOGY | ||||||
| 04/30/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $85.05 | General |
| 04/30/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $85.05 | General |
| 04/26/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: ONCOLOGY | ||||||
| 04/19/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: NEPHROLOGY | ||||||
| 04/10/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $6.78 | General |
| Category: ONCOLOGY | ||||||
| 04/09/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 2,065 | 5,324 | $910,560 | $371,910 |
| 2022 | 14 | 1,925 | 6,462 | $1.1M | $425,493 |
| 2021 | 14 | 914 | 2,231 | $473,545 | $178,004 |
| 2020 | 11 | 341 | 882 | $182,770 | $72,501 |
Total Patients
5,245
Total Services
14,899
Medicare Billing
$1.0M
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 434 | 1,281 | $288,300 | $130,076 | 45.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 52 | 1,055 | $131,875 | $65,378 | 49.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 166 | 175 | $87,550 | $36,706 | 41.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 263 | 263 | $78,900 | $33,859 | 42.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 77 | 305 | $61,000 | $29,762 | 48.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 23 | 116 | $69,600 | $20,319 | 29.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 95 | 107 | $37,450 | $15,091 | 40.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 18 | 111 | $25,625 | $15,053 | 58.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 75 | 112 | $16,800 | $7,648 | 45.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 399 | 763 | $72,485 | $6,889 | 9.5% |
| 52281 | Dilation of urethra using an endoscope | Office | 2023 | 13 | 13 | $7,150 | $3,640 | 50.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 398 | 892 | $22,300 | $3,042 | 13.6% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 21 | 21 | $4,725 | $2,251 | 47.6% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 17 | 52 | $3,900 | $1,525 | 39.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 58 | $2,900 | $671.37 | 23.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 338 | 1,201 | $270,150 | $124,156 | 46.0% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 64 | 1,178 | $147,250 | $68,285 | 46.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 137 | 711 | $163,500 | $60,469 | 37.0% |
| 52281 | Dilation of urethra using an endoscope | Office | 2022 | 137 | 148 | $83,100 | $42,546 | 51.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 28 | 208 | $124,800 | $37,740 | 30.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 254 | 254 | $76,200 | $32,146 | 42.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 129 | 153 | $57,950 | $25,139 | 43.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Facility | 2022 | 55 | 833 | $74,215 | $7,907 | 10.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 328 | 742 | $67,110 | $6,568 | 9.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 33 | 111 | $13,875 | $6,390 | 46.1% |
About David Song
David Song is a Urology healthcare provider based in Chino, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2013. The National Provider Identifier (NPI) number assigned to this provider is 1699115972.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Song has received a total of $6,713 in payments from pharmaceutical and medical device companies, with $903.07 received in 2024. These payments were reported across 240 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($4,731).
As a Medicare-enrolled provider, Song has provided services to 5,245 Medicare beneficiaries, totaling 14,899 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Chino, CA
- Active Since 07/01/2013
- Last Updated 04/10/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699115972
Products in Payments
- XTANDI (Drug) $742.98
- PENILE RECONSTRUCTION (Device) $605.43
- GENERAL - THERAPIES (Device) $568.57
- AMS (Device) $397.18
- Xtandi (Drug) $360.71
- XIAFLEX (Biological) $244.02
- LITHOVUE (Device) $241.59
- Myrbetriq (Drug) $187.36
- Erleada (Drug) $157.33
- rezum Generator (Device) $139.27
- MYRBETRIQ (Drug) $132.61
- DAV-Arista AH (Device) $122.71
- GENERAL - ERECTILE DYSFUNCTION (Device) $121.38
- Urolift - UL400 (Device) $119.62
- RESTORELLE (Device) $111.91
- ELIGARD (Drug) $104.38
- Rezum Generator (Device) $86.46
- ERLEADA (Drug) $78.99
- AMS 700 (Device) $69.09
- FEMALE INCONTINENCE (Device) $65.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.